MGX Stock Summary and Trading Ideas (Metagenomi | NASDAQ:MGX)

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.

Metagenomi trades on the NASDAQ stock market under the symbol MGX.

As of December 24, 2025, MGX stock price climbed to $1.74 with 160,869 million shares trading.

MGX has a beta of 1.16, meaning it tends to be more sensitive to market movements. MGX has a correlation of 0.06 to the broad based SPY ETF.

MGX has a market cap of $65.31 million. This is considered a Micro Cap stock.

Last quarter Metagenomi reported $9 million in Revenue and -$.55 earnings per share. This beat revenue expectation by $203,000 and exceeded earnings estimates by $.01.

The top ETF exchange traded funds that MGX belongs to (by Net Assets): VTI, VXF, IWC, AVSC, DFSU.

MGX has underperformed the market in the last year with a price return of -56.6% while the SPY ETF gained +17.3%. MGX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -20.2% and -2.8%, respectively, while the SPY returned +4.4% and +1.4%, respectively.

MGX support price is $1.64 and resistance is $1.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MGX shares will trade within this expected range on the day.